Clinical Trials Directory

Trials / Completed

CompletedNCT04365595

SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir)

Recovery in Patients With SARS-CoV-2 Associated Respiratory Failure

Status
Completed
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the current pandemic of coronavirus disease (COVID-19) that can lead to respiratory failure requiring oxygen therapy. Some patients develop acute respiratory distress syndrome (ARDS) and may die despite intensive care therapy. Currently it is unknown a) how fast patients recover after being discharged from hospital and b) what underlying predictors may influence recovery.

Detailed description

Study aims: * To evaluate subjective and objective recovery after discharge from hospital in patients with respiratory failure due to COVID-19. * To identify risk factors for COVID-19 associated respiratory failure and prolonged recovery

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaires, spirometryQuestionnaires targeting health-related quality-of-life, symptoms, anxiety and depression

Timeline

Start date
2020-06-03
Primary completion
2021-02-17
Completion
2021-02-17
First posted
2020-04-28
Last updated
2021-02-23

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04365595. Inclusion in this directory is not an endorsement.

SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) (NCT04365595) · Clinical Trials Directory